Faculty Presentations
General Overview on COPD / COPD Exacerbations
Transitioning the COPD pt. to Home NIV after Acute Hospitalization/Exacerbation
Current Activity
|
U.S. Perspective Gerard J. Criner, MD Professor of Medicine Florence P. Bernheimer Distinguished Service Chair Director of Pulmonary and Critical Care Medice and Temple Lung Center Temple University School of Medice Philadelphia, PA, USA |
Fig. 01 -
Title Slide
Fig. 02 -
Introduction
Fig. 03 -
Severe AECOPD and Mortality
Fig. 04 -
NPPV for Chronic Stable COPD
Fig. 05 -
Goals of NPPV
Fig. 06 -
Nocturnal NPPV in Stable COPD
Fig. 07 -
NPPV & Changes in PaCO2
Fig. 08 -
Time to Readmission or Respiratory Death
Fig. 09 -
Effect of NPPV
Fig. 10 -
Significant Study Features
Fig. 11 -
Factors Affecting NPPV Outcomes
Fig. 12 -
Consort Diagram
Fig. 13 -
Study Outcomes
Fig. 14 -
Baseline Demographics
Fig. 15 -
Baseline COPD Status
Fig. 16 -
Comorbidities
Fig. 17 -
NPPV Use
Fig. 18 -
NPPV at Discharge:
Secondary Endpoints
Secondary Endpoints
Fig. 19 -
NPPV & Obese COPD
Fig. 20 -
1. Predictors of Survival: COPD & Home NPPV
Fig. 21 -
2. Predictors of Survival: COPD & Home NPPV
Fig. 22 -
Interfaces for NPPV
Fig. 23 -
1. Advantages/
Disadvantages of NPPV Interfaces
Disadvantages of NPPV Interfaces
Fig. 24 -
2. Advantages/
Disadvantages of NPPV Interfaces
Disadvantages of NPPV Interfaces
Fig. 25 -
30-Day COPD readmission(s) in patients 40-64 yrs.
Fig. 26 -
Utilization of NIV:
Acute Care Hospitals
Acute Care Hospitals
Fig. 27 -
1. Transitioning NPPV Patients from Hospital to Home
Fig. 28 -
2. Transitioning NPPV Patients from Hospital to Home
Fig. 29 -
Summary
